JP2004528810A5 - - Google Patents

Download PDF

Info

Publication number
JP2004528810A5
JP2004528810A5 JP2002532655A JP2002532655A JP2004528810A5 JP 2004528810 A5 JP2004528810 A5 JP 2004528810A5 JP 2002532655 A JP2002532655 A JP 2002532655A JP 2002532655 A JP2002532655 A JP 2002532655A JP 2004528810 A5 JP2004528810 A5 JP 2004528810A5
Authority
JP
Japan
Prior art keywords
fold
cell
nos
seq
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002532655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004528810A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/030732 external-priority patent/WO2002029086A2/en
Publication of JP2004528810A publication Critical patent/JP2004528810A/ja
Publication of JP2004528810A5 publication Critical patent/JP2004528810A5/ja
Pending legal-status Critical Current

Links

JP2002532655A 2000-10-02 2001-10-02 癌組織でディファレンシャルに発現される核酸配列 Pending JP2004528810A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23727100P 2000-10-02 2000-10-02
PCT/US2001/030732 WO2002029086A2 (en) 2000-10-02 2001-10-02 Nucleic acid sequences differentially expressed in cancer tissue

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007150552A Division JP2007289196A (ja) 2000-10-02 2007-06-06 癌組織でディファレンシャルに発現される核酸配列

Publications (2)

Publication Number Publication Date
JP2004528810A JP2004528810A (ja) 2004-09-24
JP2004528810A5 true JP2004528810A5 (enExample) 2007-02-15

Family

ID=22893028

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002532655A Pending JP2004528810A (ja) 2000-10-02 2001-10-02 癌組織でディファレンシャルに発現される核酸配列
JP2007150552A Pending JP2007289196A (ja) 2000-10-02 2007-06-06 癌組織でディファレンシャルに発現される核酸配列

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007150552A Pending JP2007289196A (ja) 2000-10-02 2007-06-06 癌組織でディファレンシャルに発現される核酸配列

Country Status (5)

Country Link
US (2) US20040110668A1 (enExample)
EP (1) EP1330543A4 (enExample)
JP (2) JP2004528810A (enExample)
AU (1) AU2001294943A1 (enExample)
WO (1) WO2002029086A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7258973B2 (en) 1998-08-31 2007-08-21 Mayo Foundation For Medical Education & Research Method for detecting a differentially expressed sequence
EP1666497A3 (en) * 2000-06-02 2006-06-21 Genentech, Inc. Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
EP2280030A3 (en) 2001-04-10 2011-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
AU2002325088C1 (en) * 2001-09-14 2008-09-25 Clinical Genomics Pty. Ltd. Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
US7449548B2 (en) 2001-12-07 2008-11-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
EP2275118A3 (en) 2002-05-29 2011-10-19 DeveloGen Aktiengesellschaft Pancreas-specific proteins
WO2003106635A2 (en) * 2002-06-13 2003-12-24 Regulome Corp Functional sites
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
US7393950B2 (en) * 2002-08-29 2008-07-01 Hong Kong University Of Science & Technology Antisense oligonucleotides targeted to human CDC45
WO2005051988A2 (en) * 2003-03-03 2005-06-09 Genentech, Inc. Compositions and methods for the treatment of systemic lupus erythematosis
US20070166318A1 (en) * 2003-05-30 2007-07-19 Macina Roberto A Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
DE10332854A1 (de) * 2003-07-18 2005-02-17 Universitätsklinikum der Charité der Humboldt-Universität zu Berlin Verwendung des neu-identifizierten humanen Gens 7a5/Prognostin für Tumordiagnostik und Tumortherapie
EP1652923B1 (en) 2003-08-08 2011-10-12 Perseus Proteomics Inc. Gene overexpressed in cancer
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US20060134653A1 (en) * 2004-07-28 2006-06-22 Bayer Healthcare Llc Differential expression of genes in microsatellite instability
US8535914B2 (en) * 2005-01-21 2013-09-17 Canon Kabushiki Kaisha Probe, probe set and information acquisition method using the same
ES2565512T3 (es) * 2007-07-19 2016-04-05 bioMérieux Procedimiento de ensayo de la proteína de unión a ácidos grasos del hígado, de ACE y de CA19-9 para el diagnóstico in vitro del cáncer colorrectal
FR2919065B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
FR2919062B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal.
FR2919061B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal.
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
FR2919060B1 (fr) 2007-07-19 2012-11-30 Biomerieux Sa Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal.
FR2919064B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine all pour le diagnostic in vitro du cancer colorectal
FR2933773B1 (fr) 2008-07-10 2013-02-15 Biomerieux Sa Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal
WO2010135786A1 (en) * 2009-05-29 2010-12-02 Clinical Genomics Pty. Ltd. A method for diagnosing neoplasms and molecules for use therein
GB201004551D0 (en) 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
AU2015200751B2 (en) * 2010-03-19 2016-11-10 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors including gastrointestinal and gastric cancer
WO2018132358A1 (en) * 2017-01-10 2018-07-19 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
JP6702932B2 (ja) * 2017-12-27 2020-06-03 富士フイルム株式会社 細胞撮像制御装置および方法並びにプログラム

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2135194A1 (en) * 1992-05-22 1993-12-09 Charles L. Bevins Gastrointestinal defensins, cdna sequences and method for the production and use thereof
US5861494A (en) * 1995-06-06 1999-01-19 Human Genome Sciences, Inc. Colon specific gene and protein
US6171816B1 (en) * 1996-08-23 2001-01-09 Human Genome Sciences, Inc. Human XAG-1 polynucleotides and polypeptides
US5837841A (en) * 1996-10-11 1998-11-17 Incyte Pharmaceuticals, Inc. Human Reg protein
AU6762298A (en) * 1997-03-19 1998-10-12 Zymogenetics Inc. Secreted polypeptides with homology to xenopus cement gland proteins
EP1017707A4 (en) * 1997-08-29 2004-04-28 Human Genome Sciences Inc 29 HUMAN SECRETED PROTEINS
WO1999033963A1 (en) * 1997-12-31 1999-07-08 Chiron Corporation Metastatic cancer regulated gene
US5929033A (en) * 1998-02-10 1999-07-27 Incyte Pharmaceuticals, Inc. Extracellular mucous matrix glycoprotein
DE19817946A1 (de) * 1998-04-17 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Uterus-Normalgewebe
US6262333B1 (en) * 1998-06-10 2001-07-17 Bayer Corporation Human genes and gene expression products
EP1108021A2 (en) * 1998-08-31 2001-06-20 Bayer Corporation Human genes differentially expressed in colorectal cancer
HK1041025A1 (zh) * 1998-12-23 2002-06-28 Corixa Corporation 用於結腸癌的免疫治療和診斷的化合物及其使用方法
WO2001022920A2 (en) * 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
WO2001070979A2 (en) * 2000-03-21 2001-09-27 Millennium Pharmaceuticals, Inc. Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer

Similar Documents

Publication Publication Date Title
US10344334B2 (en) Method of diagnosing neoplasms
CA2318354A1 (en) Biomarkers and targets for diagnosis, prognosis and management of prostate disease
CA2476892C (en) Mononucleotide repeats microsatellite markers for detecting microsatellite instability
JP2007506426A5 (enExample)
KR20140122285A (ko) 방광암 검출용 소변 표지
CN111876478B (zh) 肺结节诊断标志物及应用
JP5769952B2 (ja) Eml4−alk融合遺伝子の高感度検出方法
EP1036197A1 (en) Cancer susceptibility mutations of brca2
JP2010535014A5 (enExample)
JP2005537007A5 (enExample)
US20120039887A1 (en) Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript
US20090011413A1 (en) Method for screening colon cancer cells and gene set used for examination of colon cancer
KR101206029B1 (ko) 대장암 진단용 다중 snp, 그를 포함하는 마이크로어레이및 키트 및 그를 이용한 대장암 진단 방법
JP2004187620A (ja) 腎疾患の疾患マーカーおよびその利用
CN112941179B (zh) 基因在评估口腔鳞癌中的应用
JP2005528910A5 (enExample)
JPWO2002083899A1 (ja) 癌関連遺伝子
EP2707497B1 (en) Detecting the brachyspina mutation
JP2004531241A5 (enExample)
JP2010501162A5 (enExample)
JP2007532142A (ja) 乳がん遺伝子発現バイオマーカー
KR101931614B1 (ko) 칡소의 친자감정용 조성물
JP2011518541A5 (enExample)
JP2905192B2 (ja) 遺伝子発現の定量方法
JP2007510424A (ja) 分子マーカー